|
市場調査レポート
商品コード
1375139
北米の神経毒市場の2028年までの予測- 地域別分析- 製品タイプ、用途、エンドユーザー別North America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User |
||||||
|
|
|||||||
|
|||||||
| 北米の神経毒市場の2028年までの予測- 地域別分析- 製品タイプ、用途、エンドユーザー別 |
|
出版日: 2023年08月24日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
北米の神経毒市場は、2023年の48億129万米ドルから2028年には84億1,695万米ドルに成長すると予測されています。2023年から2028年までのCAGRは11.9%と推定されます。
革新的なフェイシャルエステ製品の登場が北米神経毒市場を活性化
神経毒の市場全体は、予測期間中、顔面美容の需要増に対応するため、指数関数的に推進すると予想されます。2022年3月、Aquavit Pharmaceuticals, Inc.は、中等度から重度のほうれい線治療を目的としたA型ボツリヌス毒素「DTX-021」の治験新薬（IND）申請を発表しました。この製品は、クロストリジウム・ボツリヌス菌が産生する神経毒に由来する900kDaのタンパク質複合体を高純度に精製し、臨床試験済みの注射用神経調節剤です。また、アクアビットはDTX-022を導入することで臨床試験を加速させており、その最終承認は、神経毒の世界初の汎顔面微量注射として認知されることになります。同様に、減量傾向が続く中、胃ボトックスは非侵襲的な処置を求める患者の間で人気のある選択肢となっています。これは、内視鏡技術を用いて特定の胃の部位にボトックスを注入するものです。この技術により、胃の筋肉の収縮が制限されます。この制限により、胃の排出プロセスに時間がかかるため、患者は満腹感を長時間感じることができ、その結果、食欲が減退し、高血圧や糖尿病などの体重関連の健康問題や生活習慣病が改善されます。したがって、革新的な顔面美容製品の出現は、北米神経毒市場の成長に役立っています。
北米神経毒市場の概要
北米神経毒市場は米国、カナダ、メキシコに区分されます。米国は神経毒の最大かつ最速成長市場です。同地域の市場成長は、製品上市の増加、様々な筋疾患に対する神経毒のFDA承認の増加、高齢化人口の増加、非外科的または低侵襲美容施術の増加、美容施術の増加、低侵襲治療薬に対する需要の増加に起因しています。
北米の神経毒市場の収益と2028年までの予測（金額）
北米神経毒市場のセグメンテーション
北米の神経毒市場は、製品タイプ、用途、エンドユーザー、国に区分されます。製品タイプに基づき、北米神経毒市場はボトックス、ディスポート、ゼノミン、その他に細分化されます。ボトックスセグメントは2023年に最大の市場シェアを記録しました。
用途別では、北米神経毒市場は治療用と美容用に区分されます。2023年には、治療セグメントがより大きな市場シェアを占めました。
エンドユーザー別では、北米の神経毒市場は病院、専門クリニック、皮膚科クリニック、その他に区分されます。病院セグメントが2023年に最大の市場シェアを占めました。
国別では、北米神経毒市場は米国、カナダ、メキシコに区分されます。米国が2023年の市場シェアを独占しました。
AbbVie Inc、Hugel Inc、Ipsen SA、Medytox Inc、Merz Pharma GmbH &Co KGaA、Metabiologics、Revance Therapeutics Incなどが北米神経毒市場で事業を展開する大手企業です。
目次
第1章 イントロダクション
第2章 北米神経毒市場-要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 北米神経毒市場- 市場情勢
- 概観
- 北米PEST分析
- 専門家の見解
第5章 北米の神経毒市場-主要市場力学
- 市場促進要因
- 外見改善のための美容施術の急増
- 革新的な顔面美容製品の出現
- 市場抑制要因
- 不適切/不適当な注射技術
- 市場機会
- 神経毒による上肢筋痙縮の軽減
- 今後の動向
- 生殖補助医療（ART）用BOTA
- インパクト分析
第6章 北米神経毒市場
- 北米神経毒市場の収益予測と分析
第7章 北米神経毒市場-2028年までの収益と予測- タイプ別
- 北米神経毒市場のタイプ別収益シェア（2022年、2028年）
- ボトックス
- ディスポート
- ゼオミン
- その他
第8章 北米神経毒市場：用途別収益と2028年までの予測
- 北米神経毒市場の用途別売上高シェア（2022年および2028年）
- 治療用
- 治療用
第9章 北米神経毒市場- エンドユーザー別収益と2028年予測
- 北米の神経毒市場のエンドユーザー別収益シェア（2022年および2028年）
- 病院
- 医療スパおよび美容センター
- 皮膚科クリニック
- その他
第10章 北米神経毒市場の収益と2028年までの予測：国別分析
- 北米
- 米国
- カナダ
- メキシコ
第11章 北米神経毒市場-業界情勢
- 有機的成長戦略
- 無機的成長戦略
第12章 企業プロファイル
- Merz Pharma GmbH & Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- Medytox Inc
- Hugel Inc
- Metabiologics
第13章 付録
List Of Tables
- Table 1. North America Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
- Table 2. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 3. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 4. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 6. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Recent Organic Growth Strategies in Neurotoxins Market
- Table 12. Recent Inorganic Growth Strategies in the Neurotoxins Market
- Table 13. Glossary of Terms
List Of Figures
- Figure 1. North America Neurotoxin Market Segmentation
- Figure 2. North America Neurotoxin Market by Country
- Figure 3. North America Neurotoxin Market Overview
- Figure 4. North America Neurotoxin Market, By Type
- Figure 5. North America Neurotoxin Market, By Country
- Figure 6. North America: PEST Analysis
- Figure 7. North America Neurotoxin Market: Impact Analysis of Drivers and Restraints
- Figure 8. North America Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
- Figure 9. North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
- Figure 10. Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
- Figure 15. Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. North America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
- Figure 18. Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 23. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
- Figure 24. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
The North America neurotoxins market is expected to grow from US$ 4,801.29 million in 2023 to US$ 8,416.95 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2023 to 2028.
Emergence of Innovative Facial Aesthetic Products Fuels North America Neurotoxins Market
The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the North America neurotoxin market to grow.
North America Neurotoxins Market Overview
The North America neurotoxin market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for neurotoxins. The market growth in the region is attributed to the increasing product launches, growing FDA approvals for neurotoxins for various muscular conditions, rising aging population, increasing numbers of non-surgical or minimally invasive cosmetic procedures, increasing number of aesthetic procedures, and growing demand for minimally invasive therapeutics.
North America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)
North America Neurotoxins Market Segmentation
The North America neurotoxins market is segmented into product type, application, end user, and country. Based on product type, the North America neurotoxins market is sub segmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.
Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.
Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.
Based on country, the North America neurotoxins market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, and Revance Therapeutics Inc are among the leading companies operating in the North America neurotoxins market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurotoxins market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 North America Neurotoxin Market - by Type
- 1.3.2 North America Neurotoxin Market - by Application
- 1.3.3 North America Neurotoxin Market - by End User
- 1.3.4 North America Neurotoxin Market - by Country
2. North America Neurotoxin Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Neurotoxin Market - Market Landscape
- 4.1 Overview
- 4.2 North America PEST Analysis
- 4.3 Expert Opinion
5. North America Neurotoxin Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
- 5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
- 5.3 Market Opportunities
- 5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
- 5.4 Future Trends
- 5.4.1 BOTA for Assisted Reproductive Technology (ART)
- 5.5 Impact Analysis
6. North America Neurotoxin Market
- 6.1 North America Neurotoxin Market Revenue Forecast and Analysis
7. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Type
- 7.1 Overview
- 7.2 North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
- 7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Application
- 8.1 Overview
- 8.2 North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
- 8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Neurotoxin Market - Revenue and Forecast to 2028 - By End User
- 9.1 Overview
- 9.2 North America Neurotoxin Market Revenue Share, by End User (2022and 2028)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis
- 10.1 Overview
- 10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
- 10.1.1.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
11. North America Neurotoxins Market-Industry Landscape
- 11.1 Overview
- 11.2 Organic Growth Strategies
- 11.2.1 Overview
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
12. Company Profiles
- 12.1 Merz Pharma GmbH & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Revance Therapeutics Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Ipsen SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Medytox Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Hugel Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Metabiologics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
